8VC

8VC is a venture capital firm founded in 2012 and headquartered in Austin, Texas, with additional presence in San Francisco. The firm focuses on investing in transformative technologies across various sectors, including healthcare, logistics, IT infrastructure, biology, and government and defense. 8VC aims to partner with founders to drive innovation and create long-term economic and societal value. The firm is dedicated to enabling industry transformation by investing in emerging platforms that have the potential to replace outdated technology infrastructures, thereby fostering greater innovation and global prosperity. As a Registered Investment Adviser, 8VC is committed to its mission of supporting companies that can significantly impact their respective industries.

Sebastian Caliri

Partner

Serena Ge

Campus Associate

Bhaskar Ghosh

Partner and CTO

Alex Kolicich

Founding Partner

Seth Lieblich

Principal

Alex Moore

Partner

Jack Moshkovich

Principal

David Moskowitz

Principal

Drew Oetting

Founding Partner

Allison Pavlick

Principal

Justin Rose

Associate

David Yang

Senior Associate

Past deals in Early Venture Stage

Lumber

Series A in 2025
Lumber is an automated payroll, time-tracking, accounts payable, compliance, and onboarding platform for the construction industry.

Latent Labs

Series A in 2025
Latent Labs is making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.

Reveal Technology

Series A in 2024
Reveal Technology is a visual analytics and edge artificial intelligence (AI) company.

Numeric

Series A in 2024
Companies rely on Numeric to ensure their financial data is accurate, automate the month-end close, and generate real-time insights. Rated 4.9 / 5 on G2

Amber Therapeutics

Series A in 2024
Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system.

Luminate Medical

Venture Round in 2024
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this.

Latus Bio

Series A in 2024
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.

Edia Learning

Series A in 2024
Edia is an EdTech platform for 6-12 Math that ensures superior state test outcomes.

LightBeam.ai

Series A in 2024
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.

Harbor Health

Series A in 2024
Harbor Health is a multi-specialty clinic group based in Austin, Texas, founded in 2022. The organization focuses on delivering personalized, patient-centered healthcare by utilizing technology to enhance the patient experience. Harbor Health offers a collaborative approach to healthcare, working closely with individuals to understand their health goals and providing access to specialists when necessary. The clinic provides a variety of services, including primary care, chronic disease management, behavioral health, and overall wellness. Patients benefit from same-day and virtual appointment options, as well as conveniently located clinics, ensuring that healthcare is accessible and responsive to their needs.

Cambium

Series A in 2023
Cambium develops biomaterials for fields such as defense, space transport, aerospace, and renewable energy. Leveraging the Deep Tech convergence between synthetic biology, materials science, computation & automation, it delivers changes in advanced material performance and sustainability to improve products.

Samara

Series A in 2023
Samara is a home services company that provides home renovation, interior design, and architectural services.

Saronic

Series A in 2023
Saronic is building cutting-edge unmanned surface vehicles that enable maritime security and domain awareness by combining hardware, software, and artificial intelligence into one scalable, fully integrated platform. These vehicles integrate advanced hardware, software, and artificial intelligence to create a scalable and fully integrated platform aimed at enhancing the capabilities of naval and maritime forces. Saronic's products are designed for defense and surveillance applications, offering comprehensive operational capabilities.

Reserv

Series A in 2023
Reserv is a digital claims third-party administrator focused on optimizing property and casualty (P&C) claims through the use of modern systems. The company offers a range of solution-first products and services designed to enhance the entire claims ecosystem. By ensuring compliance with insurance carriers, Reserv serves as an incubator for testing innovative technologies and AI services, aimed at improving claims efficiency and outcomes. The company addresses critical resource challenges faced in the claims process, positioning itself as a key player in claims innovation.

Vital Bio

Venture Round in 2023
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

DataHub

Series A in 2023
DataHub Core is the #1 open source platform with a uniquely scalable and extensible metadata graph supporting manual and automated data management. DataHub Cloud is an enterprise-ready SaaS solution providing a fully-managed service of DataHub Core with additional AI-powered capabilities in discovery, observability, and governance to accelerate production-readiness of AI and data assets.

Myeloid Therapeutics

Series A in 2023
Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyte approach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.

Empassion

Venture Round in 2023
Empassion Health is a provider of comprehensive care services for patients with advanced illnesses. The company was founded in 2022.

Chaos

Series A in 2023
Chaos Industries is a technology company specializing in next-generation solutions for defense and critical industries. The company is dedicated to enhancing sensing, detection, and communication capabilities through the use of Coherent Distributed Networks (CDN). Its focus on detection and radar services supports the development of advanced defense products, allowing clients to access high-quality services tailored to their needs.

Atomic AI

Series A in 2023
Atomic AI is focused on advancing RNA drug discovery through the integration of machine learning and structural biology. The company operates a content intelligence platform that facilitates the rational design of new molecules and medicines. By leveraging engagement data from clients' analytics, Atomic AI gathers insights to create predictive reports on various topics, including optimal publishing times and distribution channels. This approach equips users with innovative strategies to develop treatments or cures for diseases by specifically targeting RNA structures.

Oula Health

Series A in 2023
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Mantra Bio

Series A in 2023
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which combines computational biology, wet lab techniques, and automation. This innovative approach allows for the design, testing, and optimization of TEVs tailored for specific therapeutic applications across diverse tissue and cellular targets. In addition to its engineering capabilities, Mantra Bio has established a scalable biomanufacturing process to ensure that these novel therapeutics can be produced reproducibly and with high purity, aiming to address intractable diseases effectively.

Second Front

Series A in 2022
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

Telegraph

Series A in 2022
Telegraph is a technology company founded in 2020 and headquartered in Chicago, Illinois, that focuses on transforming the freight rail industry through its innovative cloud-based platform. The company simplifies complex workflows and enhances collaboration among railroads, shippers, and third-party logistics providers, thereby improving visibility and insights into rail operations. By employing advanced technology, Telegraph aims to create a more sustainable and efficient supply chain, facilitating seamless logistics and streamlined operations across the freight ecosystem.

SURGE Therapeutics

Series A in 2022
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.

Invisible AI

Series A in 2022
Invisible AI Inc. is a technology company specializing in artificial intelligence-based camera systems designed for logistics and manufacturing facilities. Founded in 2018 and headquartered in San Francisco, the company offers a no-code, edge-based visual intelligence platform that enhances quality, productivity, and safety in manufacturing environments. Its low-cost, low-bandwidth cameras are strategically deployed at workstations to monitor real-time human motion, enabling clients to optimize workflow and reduce costs associated with manual assembly errors. The accompanying web dashboard provides clients with visibility and built-in intelligence to protect data while facilitating the integration, tracking, and analysis of operational practices. This comprehensive system helps clients ensure that processes are executed accurately and safely, ultimately improving overall efficiency.

Jacobi

Series A in 2022
Jacobi is a next-generation intelligence platform for investment managers to customize and scale multi-asset portfolio design. Its risk and portfolio-construction tools enable practitioners to work and communicate through intuitive storyboards. Built with a multi-asset focus, their platform facilitates the transfer of manager insights, generating better investment ideas and deeper levels of engagement between an investment manager and client. Jacobi was founded in 2014 and is headquartered in San Francisco, California.

Opto Investments

Series A in 2022
Opto Investments offers a complete solution for independent investment advisors to access private market investments.

Rephrase.ai

Series A in 2022
Rephrase.ai specializes in an AI-powered video creation technology that transforms text into animated videos featuring realistic facial representations of individuals. This innovative approach employs generative AI to analyze and learn the facial features of specific people in relation to spoken audio, allowing the system to create photorealistic visuals for any new text or audio input. The platform serves a variety of applications, enabling clients to produce training videos, personalize sales presentations, animate characters in augmented and virtual reality, and provide a visual identity for digital assistants. Through its advanced technology, Rephrase.ai enhances the way organizations communicate and engage with their audiences.

Harbor Health

Series A in 2022
Harbor Health is a multi-specialty clinic group based in Austin, Texas, founded in 2022. The organization focuses on delivering personalized, patient-centered healthcare by utilizing technology to enhance the patient experience. Harbor Health offers a collaborative approach to healthcare, working closely with individuals to understand their health goals and providing access to specialists when necessary. The clinic provides a variety of services, including primary care, chronic disease management, behavioral health, and overall wellness. Patients benefit from same-day and virtual appointment options, as well as conveniently located clinics, ensuring that healthcare is accessible and responsive to their needs.

Photys Therapeutics

Series A in 2022
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.

KeyCare

Series A in 2022
KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.

Cartography Biosciences

Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.

Fruitful

Series A in 2022
Fruitful is a financial wellness platform aimed at empowering individuals to manage their finances more effectively. The platform provides members with personalized financial advice from qualified specialists, hands-on investment management, and access to high-yield savings options. It also simplifies the banking experience by offering tools that integrate various third-party apps, bank accounts, and financial services into a single dashboard. This subscription-based model allows users to benefit from tailored banking services while enhancing their financial understanding and promoting a secure financial future.

Felux

Series A in 2022
Felux is a business-to-business marketplace and supply chain platform focused on the mining industry. The company provides a variety of services, including procurement solutions and supply chain management, facilitating the buying and selling of industrial products. Its platform enables users to source, procure, ship, finance, and analyze transactions related to steel, all in one location. This comprehensive approach allows suppliers to digitize their operations and manage their selling and distribution processes efficiently.

Seaplane IO

Series A in 2022
Seaplane IO Inc. is a technology company based in Mountain View, California, focused on developing a serverless cloud software system tailored for modern enterprises. Founded in 2020, the company enables developers to create and scale applications efficiently without the complexities of managing cloud infrastructure. Its platform supports both on-premises and cloud server deployments, allowing for deployment from any location worldwide. By facilitating multi-cloud and edge computing, Seaplane IO provides essential APIs, services, and support, empowering software developers to deliver optimized applications to users globally.

Candid Health

Series A in 2022
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

Fieldguide

Series A in 2022
Fieldguide, Inc. is an enterprise software company that provides an automation and collaboration platform specifically designed for audit and advisory firms. Founded in 2020 and based in Sacramento, California, the company offers a suite of workflow software features, including secure data requests, work plan management, reporting automation, and resource planning. The platform utilizes artificial intelligence to standardize templates and facilitate drag-and-drop report creation, helping firms streamline their project lifecycle. By enhancing productivity and client satisfaction, Fieldguide enables firms to improve their margins and foster stronger client relationships. The company is supported by notable venture capital investors, including 8VC, Floodgate, and Y Combinator.

OpenComp

Series A in 2022
OpenComp provides a compensation planning tool that helps high-growth companies make informed decisions regarding their compensation practices. Founded in 2021 by Thanh Nguyen and Nancy Connery, who were part of Salesforce's founding HR team, OpenComp serves over 2,000 organizations, including notable names like Calm, Discord, and Reddit. The platform enables companies to attract and retain top talent through fair and consistent compensation strategies. It also offers features that allow organizations to analyze the impact of compensation changes on their financials while providing benchmarking data by gender and ethnicity. OpenComp offers its services for free to companies with up to 50 employees, with tiered pricing available for larger organizations based on their specific needs. The company has secured $24 million in venture capital from notable investors, including J.P. Morgan and Marc Benioff's TIME Ventures.

180° Insurance

Series A in 2022
180° is an InsurTech company that provides insurance services. With a focus on the B2B2C model, the company builds insurance and assistance products with technology that are connected to customers' daily lives in a simple and digital way. 180° was founded in 2020 and is headquartered in Sao Paulo, Brazil.

Cellino

Series A in 2022
Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.

Rocketlane

Series A in 2022
Rocketlane is a developer of a customer onboarding platform that enhances the efficiency of implementation and onboarding projects for professional services teams. The platform facilitates collaborative project execution, time tracking, AI-enabled resource management, and project accounting, which improves communication and visibility throughout customer projects. By streamlining workflows and providing a consistent execution strategy, Rocketlane enables businesses to deliver an exceptional onboarding experience, ensuring that customers realize value quickly and effectively. Its clientele includes notable companies such as Clari, Drift, Icertis, Showpad, Uniphore, and Vidyard, among others, reflecting its global reach and impact in enhancing project governance and collaboration.

Ritten

Venture Round in 2022
Ritten operates an electronic medical records platform designed specifically for addiction treatment providers to enhance the quality of care for their patients. The platform facilitates personalized, data-informed care by offering customized workflow configurations that support the consistent and compliant delivery of complex treatment. It enables clinicians and administrators to maintain comprehensive patient records that encompass all aspects of a patient's care, including clinical notes, medications, and treatment plans. This approach allows healthcare professionals to provide tailored care while effectively tracking patient progress and needs.

Petra

Series A in 2021
Petra is a robotics company specializing in underground utility solutions. The firm has developed advanced tunneling robots designed to efficiently and safely bore utility conduits through various geological conditions, including high-grade hard rock. By enabling the undergrounding of critical utilities, Petra provides a practical and cost-effective means to construct small-diameter infrastructure, particularly in disaster-prone areas. Their technology addresses the challenges of traditional tunneling methods, making it feasible to install essential utilities in previously inaccessible locations.

Software.com

Series A in 2021
Software is transforming the world. Our mission is to transform software development. We quantify the craft by collecting data across the stack to help developers and teams learn from their data, increase productivity, and code smarter.

Surglogs

Series A in 2021
Surglogs streamlines and automates the administration of logbooks, medications, supplies, in-services, and drills in healthcare facilities. The outdated pen-and-paper method is replaced with a HIPAA compliant state of the art digital application, complemented with a desktop portal that serves as an administrative dashboard. Surglogs was founded in 2015 and headquartered in California, United States.

Quince

Series A in 2021
Quince, LLC is a retail company based in San Francisco, California, specializing in affordable luxury apparel, accessories, and home goods for both men and women. Founded in 2016, Quince offers a diverse range of products including jewelry, tops, sweaters, loungewear, leather goods, and various accessories for men, as well as bedding and bath items for the home. The company employs a manufacturer-to-consumer retail model, producing inventory on a near just-in-time basis, which allows for direct shipping to consumers. This approach not only reduces costs but also minimizes financial and environmental waste, enabling Quince to provide high-quality fashion and home products at competitive prices.

Spartan Radar

Series A in 2021
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.

Better Health

Series A in 2021
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Mindbloom

Series A in 2021
Mindbloom is a Seattle-based mental health and wellbeing company that focuses on providing at-home, clinician-prescribed psychedelic therapies, specifically ketamine therapy, for individuals experiencing anxiety and depression. Founded in 2008 by Chris Hewett and Brent Poole, Mindbloom combines behavioral science with rich media and social gaming techniques to create an engaging platform for personal development. The company aims to make mental health support accessible and effective by connecting clients with licensed clinicians who assess their health history to determine the suitability of ketamine therapy. Through this innovative approach, Mindbloom seeks to facilitate lasting improvements in mood, outlook, and overall mental well-being. The company has garnered a user base of over 30,000 individuals and has established partnerships with notable organizations, including Aetna and Sacramento State University, as well as research collaborations with institutions like UC Santa Barbara and Stanford University.

Esper

Series A in 2021
Esper is a developer of a policy collaboration platform that assists government agencies in managing public policy effectively. The company's software enables officials to integrate and transform policy data into actionable insights, promoting transparent and data-driven decision-making. By streamlining internal workflows, Esper helps create a comprehensive infrastructure that supports the entire policymaking lifecycle. The company has established partnerships with various government entities, including the New York City Police Department, Washington Department of Health, and California State Treasurer’s Office. With a workforce of over 30 employees, Esper has successfully secured over $14 million in funding to enhance its offerings and expand its reach in the public sector.

Formlogic

Series A in 2021
Formlogic is a provider of autonomous manufacturing technology focused on delivering precision components for the space and frontier industries. The company aims to revolutionize part production by addressing issues within the domestic supply chain. Its advanced technology enhances the capabilities of workers, allowing novices to achieve expert-level tolerances while increasing productivity for experienced operators. Formlogic offers rapid turnaround times, with production orders completed in weeks, and provides real-time order status updates. This approach enables industries to obtain custom machined components with close tolerances at scale, improving overall efficiency and customer experience.

Appia Bio

Series A in 2021
Appia Bio is a biotechnology company dedicated to the research and development of allogeneic cell therapies that can be readily available for patients. The company focuses on creating engineered cell therapies for various medical conditions using its innovative ACUA technology platform. This platform utilizes the biology of lymphocyte development along with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to produce CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells. By maturing and scaling healthy stem cells into these therapies, Appia Bio aims to provide safe and targeted cancer treatments, thereby enhancing accessibility to off-the-shelf cell therapies for physicians and patients alike.

Seed Health

Series A in 2021
Seed Health is a biotechnology company focused on developing health supplements that utilize bacteria to enhance human and environmental health. The company collaborates with academic researchers to advance innovations in microbial sciences, offering a range of products that combine probiotics and prebiotics. These supplements are designed to provide systemic benefits, addressing areas such as digestive health, skin health, heart health, and micronutrient synthesis. Through its work, Seed Health aims to deliver live biotherapeutics that support overall well-being and contribute to scientific advancements in the field.

Polly

Series A in 2021
Polly is a fun way to create anonymous polls for your friends on Snapchat and Instagram stories. Create a poll, attach it to your story, and discover what your friends think.

Polly

Series A in 2021
PollyEx, Inc. operates a loan trading platform focused on the mortgage capital markets, facilitating transactions between buyers and sellers of mortgage loans. Founded in 2017 and based in San Francisco, California, PollyEx enhances loan sale execution through its cloud-based platform, which integrates with buyers and sellers via API, thereby increasing liquidity and automating various functions within capital markets. The platform aims to provide pricing transparency and improve operational efficiency for lenders, enabling them to make informed decisions throughout the lifecycle of a loan.

Baton

Series A in 2021
Baton is the Silicon Valley based technology innovation lab for Ryder, a Fortune 500 logistics company that owns 260k trucks and manages $7.4B of freight. Before being acquired by Ryder in September, 2022, Baton was a venture backed start up that was voted the #4 most disruptive company in freight! (Amazon was #3) Our mission is to eliminate waste in supply chain by creating a digital platform that uses AI to improve how freight is planned. There are 500 million hours wasted in trucking each year, over 3 billion gallons of fuel wasted per year from trucks idling, and 1 in 5 trucks on the road driving empty at any given point. This has a massive impact on the environment, the lives of millions of drivers, and ultimately, the cost of transportation that we all pay.

Elemy

Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in areas such as autism, ADHD, OCD, depression, social anxiety, and bipolar disorder. Launched in April 2020, the company utilizes a technology-driven care model that modernizes traditional healthcare delivery through in-home services. This approach enhances access to care, improves clinical outcomes, and reduces costs. Elemy's platform offers free autism assessments and matches children with therapists to develop individualized treatment plans tailored to their specific needs. The multidisciplinary clinical team implements an integrated treatment model that has demonstrated significant improvements in behavior. Backed by notable venture capital and healthcare investors, Elemy is committed to transforming the landscape of childhood mental health care.

Edgybees

Series A in 2021
Edgybees Ltd. is a technology company based in Palo Alto, California, founded in 2016, that specializes in augmented reality solutions for high-speed applications. Its platform enables real-time, immersive AR experiences for various moving objects, including drones, cars, and wearable devices, by overlaying three-dimensional visuals on live video feeds. This capability is particularly beneficial for sectors such as emergency response, homeland security, real estate, urban planning, and agriculture. The company's offerings include a developer SDK and back-end SaaS services designed to support a wide range of consumer and commercial applications. Edgybees also provides gaming solutions like Droneprix AR and Drone FX, targeting both the entertainment and industrial markets. Co-founded by Menashe Haskin, Adam Kaplan, and Nitay Megides, Edgybees aims to enhance operational effectiveness in military and emergency contexts through its innovative AR technology.

BigHat Biosciences

Series A in 2021
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Raydiant

Series A in 2021
Raydiant, Inc. is a company that specializes in creating an experience platform designed to enhance the interaction between employees, customers, and brands. Founded in 2017 and based in San Francisco, Raydiant offers a variety of solutions, including kiosks, virtual agents, and multimedia devices, aimed at connecting and controlling screens across numerous industries such as banking, healthcare, retail, and education. The company's platform allows businesses to manage and display digital content effectively, transforming traditional displays into interactive digital signage that fosters engaging in-store experiences. With a client base of nearly 5,500 brands, Raydiant serves both small and large enterprises, helping them improve operations and customer engagement through innovative technology.

Myeloid Therapeutics

Series A in 2021
Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyte approach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.

Kojo

Series A in 2020
Kojo is a cloud-based construction management software company that provides an all-in-one platform for contractors to manage their material and inventory needs. Founded in 2018 and based in San Francisco, Kojo's system focuses on streamlining materials management and procurement processes, enhancing profitability for construction companies. By integrating various stakeholders, including field teams, procurement, and distributors, Kojo simplifies the supply chain through automation, facilitating the ordering and tracking of materials. This approach enables contractors to ensure timely delivery of materials to job sites, thereby improving operational efficiency.

Cellares

Series A in 2020
Cellares Corporation, founded in 2019 and based in South San Francisco, California, focuses on advancing cell therapy for cancer treatment by addressing the significant manufacturing challenges associated with these therapies. The company has developed the Cell Shuttle, an automated and closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of multiple patient doses, achieving tenfold scalability compared to traditional methods, while also reducing process failure rates by three times and lowering manufacturing costs by up to 70 percent. Cellares aims to make life-saving cell therapies more affordable and widely accessible to patients in need, thereby accelerating the development and availability of these critical treatments.

Dren Bio

Series A in 2020
Dren Bio is a biotechnology company that specializes in protein engineering technologies designed to target and deplete pathogenic cells, protein aggregates, and other disease-causing agents. With a focus on hematologic neoplasms, solid cancers, autoimmune disorders, and diseases related to protein aggregation, the company aims to provide innovative solutions for healthcare professionals in their efforts to combat various serious diseases. Operating under a holding company model, Dren Bio develops multiple projects as standalone assets, seeking to create value through its diverse portfolio of biotechnology initiatives.

Sonoma Biotherapeutics

Series A in 2020
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

Sonoma Pharmaceuticals

Series A in 2020
Sonoma Pharmaceuticals, Inc. is a global healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products for diverse applications, including wound care, dermatology, animal health, eye care, and oral care. Based in Woodstock, Georgia, and incorporated in 1999, the company offers over 100 commercially available products worldwide. Its key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for managing dermatoses; Celacyn gel for scar management; and SebuDerm for seborrhea relief. Additionally, Sonoma provides Acuicyn for eye care, Microcyn for expedited wound healing, and various products targeting animal health, such as MicrocynAH and MicrocynVS. The company's focus on addressing unmet medical needs in chronic skin conditions significantly contributes to enhancing patient care while aiming to reduce overall healthcare costs. Sonoma Pharmaceuticals was previously known as Oculus Innovative Sciences, Inc. and rebranded in December 2016.

Hexagon Bio

Series A in 2020
Hexagon Bio, Inc. is a biotechnology company based in Menlo Park, California, focused on discovering novel drugs for diseases that lack effective treatments. Established in 2016, the company utilizes a data-driven approach that combines genomics, synthetic biology, and computational techniques. By mining genomic data from fungal genomes, Hexagon Bio aims to identify targeted small molecule therapeutics. Its proprietary platform leverages data science to engineer drugs from DNA sequences, enabling the identification of small molecule inhibitors that interact with specific target proteins. This innovative method allows researchers to tap into the global metagenome, facilitating the development of new medicines aimed at improving patient outcomes.

Sirona

Series A in 2020
Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.

Habi

Series A in 2020
Habi is a technology-driven real estate company based in Bogotá, Colombia, founded in 2019. The firm focuses on simplifying the home buying and selling process for middle-class customers in Latin America by utilizing a proprietary pricing algorithm and scalable processes. Habi's platform aims to reduce the time and risks associated with traditional real estate transactions, allowing clients to buy and sell their homes more efficiently. By combining advanced analytical tools with human insight, Habi eliminates the need for intermediaries and provides clients with the necessary information to make informed decisions in the real estate market.

High Definition Vehicle Insurance

Series A in 2020
HDVI is a technology-first commercial insurance provider. The company assesses risk using historical and real-time telematics data and provides tools and services that help fleets increase safety, rewards safe driving, and delivers efficient and fair claims processing. HDVI is headquartered in Chicago with additional offices in Greenville, South Carolina; Columbus, Ohio; Portland, Oregon; Dallas and San Francisco. High Definition Vehicle Insurance, Inc. is a licensed property casualty insurance agent with products underwritten by various insurance companies. For more information, visit https://hdvi.com.

Mantra Bio

Series A in 2020
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which combines computational biology, wet lab techniques, and automation. This innovative approach allows for the design, testing, and optimization of TEVs tailored for specific therapeutic applications across diverse tissue and cellular targets. In addition to its engineering capabilities, Mantra Bio has established a scalable biomanufacturing process to ensure that these novel therapeutics can be produced reproducibly and with high purity, aiming to address intractable diseases effectively.

Beacon

Series A in 2020
Beacon is a digital supply chain and freight platform developed to optimize supply chains with insights and visibility. It offers a freight forwarding service across all modes integrated with its end-to-end visibility platform, connecting each stage of the supply chain to deliver a record of all the information teams need. From bookings to order management, live tracking, and document management, Beacon will move goods with transparency and efficiency, whilst the secure cloud-based software improves accuracy and saves time. The company was founded in 2018 by Fraser Robinson and Dmitri Izmailov and is headquartered in London, England, United Kingdom.

Hearth

Series A in 2020
Hearth is a financial technology platform designed specifically for home improvement contractors. It offers a suite of tools that assist these contractors in managing and growing their businesses. The platform provides essential financial resources, including financing advice, invoicing, payment collections, and insurance products. By enabling contractors to send quotes, contracts, invoices, and financing options from any location, Hearth facilitates a seamless process for closing deals. This comprehensive approach helps contractors streamline operations and improve their overall business efficiency.

Octant Bio

Series A in 2020
Octant Bio is a biotechnology company focused on developing synthetic technology aimed at enhancing health and treating diseases. The company employs a platform that integrates synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. This advanced technology allows scientists to utilize machine learning techniques to engineer small molecules capable of interacting with multiple receptors, thereby creating new possibilities for the treatment of complex diseases.

Unlearn.AI

Series A in 2020
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Motherly

Series A in 2020
Motherly, Inc. is a digital platform that focuses on supporting millennial mothers throughout their parenting journey, from conception to college. Established in 2015 and based in Menlo Park, California, the company provides a wealth of resources including articles, videos, and guides that cover diverse topics such as parenting advice, wellness tips, and lifestyle content. The platform offers information on various aspects of motherhood, including child-rearing, self-care, home management, beauty, and career coaching. Additionally, Motherly sells a range of products aimed at mothers, including registry essentials and holiday items. The company, formerly known as Motherly Media, Inc., rebranded in March 2018 to better reflect its mission of redefining motherhood and fostering a community-driven lifestyle brand.

MycoWorks

Series A in 2020
MycoWorks is a biotechnology company focused on developing sustainable, non-plastic and non-animal materials. Utilizing fungal mycelium, the company creates biodegradable alternatives to plastic foams, synthetic textiles, engineered woods, and leather. Their innovative products are designed for various applications, including aerospace, automobiles, apparel, and architectural interiors. By leveraging agricultural byproducts in a carbon-negative process, MycoWorks enables clients to access new types of leather that are grown rapidly and sustainably. This approach not only addresses environmental concerns but also offers practical solutions for industries seeking eco-friendly materials.

Sonoma Biotherapeutics

Series A in 2020
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

Legalpad

Series A in 2020
Legalpad Inc. is a Seattle-based company founded in 2018 that focuses on streamlining work visa applications for startups and their employees. By combining advanced software with human support, Legalpad simplifies the legal processes associated with O-1, EB-1, H-1B, and B-1 visas. The platform is designed to automate repeatable legal tasks and workflows, thereby enhancing efficiency in the visa application process. Legalpad aims to connect global talent with opportunities, facilitating cross-border employment for individuals and enabling startups to navigate the complexities of hiring international talent.

Nines

Series A in 2019
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Epirus

Venture Round in 2019
Epirus, Inc. is a company focused on developing advanced defense technologies that utilize artificial intelligence and directed energy systems. Based in Hawthorne, California, it specializes in solid-state, software-defined high-power microwave systems designed to counter unmanned aircraft and other asymmetric threats. The company's flagship product, ELECTROMAGNETIC PULSE, functions as a drone countermeasure by delivering multiple beams simultaneously, effectively disrupting and neutralizing aerial threats. Additionally, Epirus employs AI and computer vision to enhance its capabilities in detecting and tracking various targets of interest. Founded in 2018, Epirus aims to provide innovative solutions for both national security and commercial applications, optimizing power management and efficiency in electronic warfare scenarios.

Jacobi

Series A in 2019
Jacobi is a next-generation intelligence platform for investment managers to customize and scale multi-asset portfolio design. Its risk and portfolio-construction tools enable practitioners to work and communicate through intuitive storyboards. Built with a multi-asset focus, their platform facilitates the transfer of manager insights, generating better investment ideas and deeper levels of engagement between an investment manager and client. Jacobi was founded in 2014 and is headquartered in San Francisco, California.

Vector

Series A in 2019
Vector is the mobile-first workflow and transportation management platform for shippers, logistics brokers, and carriers. Their technology enables streamlined communication and transparency in the operations of logistics and field services companies.

Tetrate

Series A in 2019
Tetrate.io, Inc. is a company founded in 2017 and based in San Francisco, California, that specializes in application management for hybrid and multi-cloud environments. It offers an enterprise-ready service mesh platform designed to simplify the complexities faced by DevOps, security, and network administrators when managing modern cloud application infrastructures. The platform enables development teams to run and manage microservices efficiently, facilitating the modernization of applications and easing the transition to public cloud adoption for businesses. By partnering with enterprises on their app modernization journeys, Tetrate supports the development and deployment of microservices across various workloads and environments.

Outrider

Series A in 2019
Outrider, Inc. is a software company that specializes in automating logistics hubs through the use of electric, self-driving trucks. Established in 2017 and based in Golden, Colorado, Outrider provides a software-as-a-service (SaaS) solution designed for customer-owned freight and transportation fleets. The company offers a comprehensive system comprised of web-based management software, autonomous driving controls for electric yard trucks, and necessary site infrastructure. Its technology automates various yard operations, including the movement of trailers and the engagement and disengagement of trailer connections, thereby eliminating hazardous and repetitive manual tasks. By focusing on the development of zero-emission systems, Outrider aims to enhance safety and efficiency for large enterprises reliant on logistics.

Vontive

Series A in 2019
Vontive is an innovative embedded mortgage platform designed to streamline the financing of investment properties. It offers a no-code, white-label solution that enables businesses serving real estate investors to establish their own mortgage services within a short timeframe. This platform not only creates a new revenue stream for retail brands but also integrates financial institutions through a debt marketplace, allowing new investors to participate in the real estate market. Founded by experienced professionals from Freddie Mac and Palantir, Vontive simplifies capital allocation and provides real estate investors with access to predictable and cost-effective financing, enhancing their ability to compete with cash buyers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.